LBA
THC icon

Letko, Brosseau & Associates’s Tenet Healthcare THC Stock Holding History

Letko, Brosseau & Associates’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,300
Closed -$705K – 110
2024
Q2 		$705K Sell
5,300
-1,123,651
-100% -$135M 0.01% 83
2024
Q1 		$119M Sell
1,128,951
-20,625
-2% -$1.85M 2.06% 17
2023
Q4 		$86.9M Sell
1,149,576
-17,205
-1% -$1.09M 1.58% 24
2023
Q3 		$76.9M Sell
1,166,781
-13,100
-1% -$979K 1.51% 24
2023
Q2 		$96M Sell
1,179,881
-13,655
-1% -$972K 1.79% 21
2023
Q1 		$70.9M Sell
1,193,536
-3,397
-0.3% -$189K 1.33% 28
2022
Q4 		$58.4M Buy
1,196,933
+177,691
+17% +$8.21M 1.05% 33
2022
Q3 		$52.6M Buy
1,019,242
+166,125
+19% +$9.86M 1.04% 32
2022
Q2 		$44.8M Buy
853,117
+61,370
+8% +$4.27M 0.79% 44
2022
Q1 		$68.1M Sell
791,747
-225,235
-22% -$18.5M 1.02% 30
2021
Q4 		$83.1M Sell
1,016,982
-58,820
-5% -$4.3M 1.19% 30
2021
Q3 		$71.5M Sell
1,075,802
-154,495
-13% -$11M 1.03% 34
2021
Q2 		$82.4M Sell
1,230,297
-173,251
-12% -$10.7M 1.1% 32
2021
Q1 		$73M Sell
1,403,548
-650,272
-32% -$32.9M 1% 38
2020
Q4 		$82M Sell
2,053,820
-451,145
-18% -$14.6M 1.12% 27
2020
Q3 		$61.4M Sell
2,504,965
-413,210
-14% -$10.6M 0.96% 40
2020
Q2 		$52.8M Buy
2,918,175
+645,600
+28% +$12.7M 0.78% 49
2020
Q1 		$32.7M Sell
2,272,575
-65,335
-3% -$1.88M 0.56% 51
2019
Q4 		$88.9M Sell
2,337,910
-138,875
-6% -$4.16M 0.89% 36
2019
Q3 		$54.8M Buy
2,476,785
+391,475
+19% +$8.34M 0.56% 51
2019
Q2 		$43.1M Buy
2,085,310
+425,965
+26% +$9.82M 0.43% 58
2019
Q1 		$47.9M Sell
1,659,345
-36,900
-2% -$911K 0.48% 55
2018
Q4 		$29.1M Sell
1,696,245
-71,850
-4% -$1.74M 0.32% 65
2018
Q3 		$50.3M Sell
1,768,095
-67,625
-4% -$2.23M 0.47% 58
2018
Q2 		$61.6M Sell
1,835,720
-126,630
-6% -$3.94M 0.56% 55
2018
Q1 		$47.6M Sell
1,962,350
-36,350
-2% -$724K 0.45% 57
2017
Q4 		$30.3M Buy
+1,998,700
New +$28.1M 0.27% 66

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Letko, Brosseau & Associates's THC Position: Q3 2024 in Review

Letko, Brosseau & Associates sold out of Tenet Healthcare (THC) in Q3 2024, closing a stake of 5,300 shares — an estimated $705K sold.

Letko, Brosseau & Associates first reported a position in THC in Q4 2017 and held it in 27 quarters. The position peaked at $119M in Q1 2024. 603 funds tracked by Wall St. Rank hold THC as of Q3 2024.

  • Letko, Brosseau & Associates reported no remaining Tenet Healthcare position as of Q3 2024 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 5,300 Tenet Healthcare shares in Q3 2024, an estimated $705K.
  • Letko, Brosseau & Associates first reported a position in Tenet Healthcare in Q4 2017 and held it in 27 quarters.
  • Letko, Brosseau & Associates's Tenet Healthcare position peaked at $119M in Q1 2024.
  • 603 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2024, filed 7 Nov 2024.